The overall goals of this K24 award are to 1) contribute to our understanding of the etiology and prevention of digestive diseases through patient-oriented research (POR) that synthesizes rigorous epidemiological methods with novel molecular correlates of disease;2) educate and mentor the next generation of clinician investigators in gastroenterology (GI). The principal investigator (PI), a leading clinical researcher in GI, has an established track record of mentoring fellows and junior faculty within the outstanding research and training environment of the Massachusetts General Hospital (MGH) GI Unit, the Harvard School of Public Health (HSPH), and the Channing Laboratory, which each offer access to motivated and talented trainees. Many of the PI's trainees have successfully secured their own career development awards and collectively have been lead authors on 17 publications in high-impact journals. The PI's outstanding institutional support, access to core resources, and successful and well-funded research portfolio has facilitated his mentoring activities and will be sustained over the time period of the award. The PI's career development objectives are as follows: 1) sustain and expand a POR program in colorectal cancer (CRC) and inflammatory bowel disease (IBD) to provide opportunities for trainees to conduct high impact POR that will enable them to launch independent careers;2) implement a highly structured, individualized, and competency-based mentoring plan to maximize trainee research productivity and prepare for careers in POR;3) become a more effective mentor through didactic training;4) develop new skills in the analysis and interpretation of high-dimensional data;5) assume local and national leadership in programmatic efforts to systematically improve mentoring of early POR investigators. To achieve these goals, the PI will offer mentored research studies for trainees which draws upon diverse study designs and data, including: 1) analytic epidemiological studies to identify lifestyle or environmental determinants of disease;2) investigation of these lifestyle factors in the context of molecular biomarkers to better elucidate their role in the disease pathogenesis;3) validation of these findings within intervention studies to further establish causality. As examples of this approach, the PI will mentor fellows and junior faculty in POR investigations of the role of inflammation in colorectal neoplasia and vitamin D in IBD. These hypothesis-based studies will provide fresh insights into the potential mechanisms involved in CRC and IBD pathogenesis and strategies for risk modification for individuals at high risk. Moreover, this research offers rich opportunities for junior investigators to be mentored within the full continuum of clinical and molecular epidemiological investigation. The PIs research infrastructure will allow rapid and efficient exploration of future hypotheses related to lifestyle, biochemical, and genetic risk factors for CRC and IBD that can serve as a platform for additional trainee projects and career award applications, thereby facilitating the emergence of the PI's trainees as the next generation of independent clinical investigators.

Public Health Relevance

Colorectal cancer (CRC) is the leading cause of GI-related deaths and the second leading cause of cancer death in the U.S.;inflammatory bowel disease (IBD) afflicts 1.4 million Americans with annual direct healthcare costs exceeding $6 billion and even greater indirect costs related to lost economic productivity. This project provides mentored research opportunities to advance our understanding of novel risk factors, particularly those with potential to be modified, in relation to CRC or IBD incidence in the context of molecular and genetic markers of risk.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-2 (J2))
Program Officer
Podskalny, Judith M,
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts General Hospital
United States
Zip Code
Kim, Sun A; Inamura, Kentaro; Yamauchi, Mai et al. (2016) Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis. Br J Cancer 114:199-206
Ogino, Shuji; Nishihara, Reiko; VanderWeele, Tyler J et al. (2016) Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine. Epidemiology 27:602-11
Giannakis, Marios; Mu, Xinmeng Jasmine; Shukla, Sachet A et al. (2016) Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma. Cell Rep :
Lochhead, Paul; Khalili, Hamed; Ananthakrishnan, Ashwin N et al. (2016) Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 14:818-824.e6
Cao, Yin; Nishihara, Reiko; Qian, Zhi Rong et al. (2016) Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes. Gastroenterology 151:879-892.e4
Hanyuda, Akiko; Kim, Sun A; Martinez-Fernandez, Alejandro et al. (2016) Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer. Ann Surg Oncol 23:908-17
Garcia-Albeniz, Xabier; Rudolph, Anja; Hutter, Carolyn et al. (2016) CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk. Br J Cancer 114:221-9
Song, Mingyang; Hu, Frank B; Spiegelman, Donna et al. (2016) Long-term status and change of body fat distribution, and risk of colorectal cancer: a prospective cohort study. Int J Epidemiol 45:871-83
Joshi, Amit D; Andersson, Charlotte; Buch, Stephan et al. (2016) Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies. Gastroenterology 151:351-363.e28
Song, Mingyang; Nishihara, Reiko; Cao, Yin et al. (2016) Marine ω-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer Characterized by Tumor-Infiltrating T Cells. JAMA Oncol 2:1197-206

Showing the most recent 10 out of 91 publications